Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)

NCT05616338 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05616338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05616338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
November 29, 2022
Completion date
March 16, 2023
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic bronchopulmonary aspergillosis (abpa), severe asthma